Down-regulation of drs mRNA in human colon adenocarcinomas
✍ Scribed by Misuzu Shimakage; Kunimitsu Kawahara; Nobuteru Kikkawa; Toshiyuki Sasagawa; Masuo Yutsudo; Hirokazu Inoue
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- French
- Weight
- 655 KB
- Volume
- 87
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Human colon cancer cell lines express epidermal growth factor (EGF) mRNA, secrete EGF and may respond to it __via__ the cell‐surface EGF receptor (EGFR). Expression of these molecules in human colon and colon tumor, however, is not clear. Reverse transcription‐polymerase chain reaction
## Abstract Recently, the anti‐tumor activity of N‐myc downstream‐regulated gene 2 (NDRG2) was elucidated, but the molecular mechanism of how NDRG2 works as a tumor suppressor is not well known. To determine the function of NDRG2 as a tumor suppressor, we established stable cell lines expressing ND
interleukin-1 (IL-1) has a crucial role in host defenses, inflammatory processes, and tissue homeostasis. A wide variety of cells produce this protein in response to a number of extracellular stimuli including microorganisms, antigenic stimuli, and products from other cells. Regulation of IL-1 produ
## Abstract Although several lines of evidence implicate cAMP in the regulation of intestinal cell proliferation, the precise role of this second messenger in the control of the human colon cancer cell cycle is still unclear. In order to investigate the role of cAMP in HT29 cell proliferation, we h
## Abstract The potential of the calcium‐entry blocker flunarizine in modulating the cytotoxicity of doxorubicin was investigated in human colon‐adenocarcinoma cell lines sensitive to (LoVo) or with experimentally induced resistance (LoVo/DX) to doxorubicin. Exposure to 1 to 2 m̈g/ml flunarizine fo